Philips to halt CPAP sales in the U.S. as it takes $393 million provision

Philips on Monday said it will halt the sales of new sleep-therapy devices in the U.S., as part of a broader settlement that led the company to take a €363 million ($393 million) provision.

Previous post China’s luxury market is bouncing back with new areas of opportunity
Next post By one measure, Elon Musk has fallen into second place in world wealth rankings